AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 277 filers reported holding AMICUS THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.99 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,262,086 | -3.2% | 103,790 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $1,303,602 | +18.2% | 103,790 | +4.3% | 0.00% | +50.0% |
| Q1 2023 | $1,103,344 | -9.2% | 99,490 | 0.0% | 0.00% | -33.3% |
| Q4 2022 | $1,214,773 | +106.6% | 99,490 | +76.7% | 0.00% | +200.0% |
| Q3 2022 | $588,000 | -76.6% | 56,290 | -75.9% | 0.00% | -83.3% |
| Q2 2022 | $2,509,000 | +371.6% | 233,559 | +316.1% | 0.01% | +500.0% |
| Q1 2022 | $532,000 | +0.2% | 56,130 | +22.0% | 0.00% | 0.0% |
| Q4 2021 | $531,000 | -80.4% | 46,000 | -60.9% | 0.00% | -83.3% |
| Q4 2020 | $2,713,000 | +47.7% | 117,502 | -9.7% | 0.01% | +20.0% |
| Q3 2020 | $1,837,000 | +1896.7% | 130,107 | +2037.1% | 0.01% | – |
| Q2 2020 | $92,000 | +64.3% | 6,088 | 0.0% | 0.00% | – |
| Q1 2020 | $56,000 | -56.6% | 6,088 | -53.8% | 0.00% | – |
| Q4 2019 | $129,000 | – | 13,177 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 10,524,022 | $127,972,108 | 12.11% |
| Perceptive Advisors | 27,692,917 | $336,745,870 | 11.23% |
| Redmile Group, LLC | 16,944,621 | $206,046,591 | 9.80% |
| Finepoint Capital LP | 1,489,025 | $18,106,544 | 9.02% |
| CM Management, LLC | 450,000 | $5,472,000 | 5.81% |
| Avoro Capital Advisors LLC | 27,400,000 | $333,184,000 | 5.20% |
| MPM BioImpact LLC | 716,139 | $8,708,250 | 2.32% |
| Artal Group S.A. | 4,062,567 | $49,401 | 2.12% |
| SECTORAL ASSET MANAGEMENT INC | 803,464 | $9,770,122 | 1.90% |
| GREAT POINT PARTNERS LLC | 857,000 | $10,421,120 | 1.90% |